US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery – ET HealthWorld | Pharma
Bengaluru: The US Food and Drug Administration approved nearly 50 per cent more novel drugs in 2023 than in 2022, ...
Read more
US FDA places clinical hold on Iovance’s lung cancer treatment trial – ET HealthWorld | Pharma
New Delhi: The US Food and Drug Administration has placed a clinical hold on iovance Biotherapeutics’ lung cancer therapy trial ...
Read more
Lupin receives US FDA approval for Loteprednol Etabonate Ophthalmic Suspension, 0.2 per cent – ET HealthWorld | Pharma
Mumbai: Lupine Limited announced that it has received approval from the United States Food and Drug Administration (US FDA) for ...
Read more
US FDA turns down full approval of Amgen lung cancer drug Lumakras – ET HealthWorld | Pharma
New Delhi: The US health regulator on Tuesday declined to grant traditional approval to Amgen‘s Lumakras for treating lung cancer ...
Read more
Alembic Pharmaceuticals receives eight ANDA approvals from US FDA in Q3FY24 – ET HealthWorld | Pharma
Mumbai: Alembic Pharmaceuticals Limited announced that it has received US Food & Drug Administration (USFDA) approvals on eight of its ...
Read more
Alembic Pharmaceuticals receives eight ANDA approvals from US FDA in Q3FY24 – ET HealthWorld | Pharma
Mumbai: Alembic Pharmaceuticals Limited announced that it has received US Food & Drug Administration (USFDA) approvals on eight of its ...
Read more
Alembic Pharmaceuticals receives eight ANDA approvals from US FDA in Q3FY24 – ET HealthWorld | Pharma
Mumbai: Alembic Pharmaceuticals Limited announced that it has received US Food & Drug Administration (USFDA) approvals on eight of its ...
Read more